基因和药物介导的SERCA2a激活恢复了糖尿病小鼠的心脏功能和代谢平衡
Soojeong Kang1, Abdul Majid2, Nadjib Hammoudi3
1Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
|October 8, 2025
概括
激活/内等质网膜Ca2+-ATPase 2a (SERCA2a) 通过增强心脏新陈代谢,线粒体功能和脂质平衡来改善糖尿病心肌病. 这种方法为糖尿病心脏病提供了潜在的治疗方法.
科学领域:
- 心脏病学 心脏病学
- 代谢疾病 代谢疾病
- 分子生物学分子生物学
背景情况:
- 糖尿病心肌病是一种严重的糖尿病并发症.
- 减少了体/内等质网膜的Ca2+-ATPase 2a (SERCA2a) 活动会损害心脏功能.
- 将SERCA2a与心脏代谢联系在一起的机制尚不清楚.
研究的目的:
- 研究SERCA2a激活对糖尿病人的心脏功能和新陈代谢的影响.
- 评估药理和基因治疗方法,以增强糖尿病心脏中的SERCA2a活性.
主要方法:
- 使用了瘦素缺乏 (Ob/ob) 糖尿病小鼠.
- 给出了一种新的SERCA2a激动剂 (CDN1163) 和AAV9介导的SERCA2a过度表达的基因传递.
- 在高葡萄糖和氧化应激下对H9C2肌细胞进行了体外研究.
主要成果:
- 两种CDN1163和AAV9-SERCA2a治疗都改善了脂质平衡和心脏能量.
- 增强的SERCA2a活性促进了线粒体生物发生,氧化酸化和ATPase活性.
- 在体外,SERCA2a恢复使线粒体功能正常化,并减少氧化应激和细胞损伤.
- 治疗策略改善了糖尿病小鼠的透缩功能.
结论:
- 激活SERCA2a是一种有前途的治疗策略,用于糖尿病心肌病.
- 益处包括改善心脏能量,脂质新陈代谢和线粒体功能.
- 准SERCA2a可能会减轻糖尿病心脏并发症.
相关概念视频
Type I Diabetes II: Pathophysiology
121
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
121
Type II Diabetes II: Pathophysiology
36
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
36
Diabetic Nephropathy
49
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
49


